166 related articles for article (PubMed ID: 10099044)
1. The action of 10 mg famotidine versus 200 mg cimetidine: onset and magnitude of antisecretory action within the first 2 hours after administration.
Decktor D; Houle JM; Pierce CH
Am J Ther; 1998 Mar; 5(2):97-100. PubMed ID: 10099044
[TBL] [Abstract][Full Text] [Related]
2. Determination of the time of onset of action of ranitidine and famotidine on intra-gastric acidity.
Gardner JD; Ciociola AA; Robinson M; McIsaac RL
Aliment Pharmacol Ther; 2002 Jul; 16(7):1317-26. PubMed ID: 12144582
[TBL] [Abstract][Full Text] [Related]
3. Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine.
Hamilton MI; Sercombe J; Pounder RE
Aliment Pharmacol Ther; 2001 Oct; 15(10):1579-83. PubMed ID: 11563997
[TBL] [Abstract][Full Text] [Related]
4. Low-dose famotidine and effervescent cimetidine in healthy subjects: a placebo-controlled overnight pH study.
Reilly TG; Grimley CE; Usselmann B; Cottrell J; Mann SG; Raskin S; Nwokolo CU
Aliment Pharmacol Ther; 1998 May; 12(5):469-74. PubMed ID: 9663728
[TBL] [Abstract][Full Text] [Related]
5. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
Sakaguchi M; Ashida K; Umegaki E; Miyoshi H; Katsu K
J Clin Gastroenterol; 1995; 20 Suppl 2():S27-31. PubMed ID: 7594334
[TBL] [Abstract][Full Text] [Related]
6. Comparison of gastric mucosal surface pH response times after intravenous administration of histamine2-receptor antagonists.
Katsu K; Yabe S
Clin Ther; 1995; 17(3):433-10. PubMed ID: 7585847
[TBL] [Abstract][Full Text] [Related]
7. Nocturnal intragastric acidity after over-the-counter doses of famotidine, ranitidine or placebo.
Grimley CE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
Aliment Pharmacol Ther; 1997 Oct; 11(5):881-5. PubMed ID: 9354196
[TBL] [Abstract][Full Text] [Related]
8. Statistical interpretation of the antisecretory effect of famotidine measured by intragastric pH-metry.
Hunyady B; Juricskay I; Nagy L; Garamszegi M; Vincze A; Mózsik G
Eur J Clin Pharmacol; 1996; 50(6):449-56. PubMed ID: 8858270
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of over-the-counter famotidine and calcium carbonate antacid on postprandial gastric acid. A randomized controlled trial.
Feldman M
JAMA; 1996 May; 275(18):1428-31. PubMed ID: 8618369
[TBL] [Abstract][Full Text] [Related]
10. Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors.
Tutuian R; Katz PO; Ahmed F; Korn S; Castell DO
Aliment Pharmacol Ther; 2002 Mar; 16(3):473-7. PubMed ID: 11876700
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of intragastric acidity in healthy subjects dosed with ranitidine 75 mg: a comparative study with cimetidine and placebo.
Grimley CE; Constantinides S; Snell CC; Mills JG; Nwokolo CU
Aliment Pharmacol Ther; 1997 Oct; 11(5):875-9. PubMed ID: 9354195
[TBL] [Abstract][Full Text] [Related]
12. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
Ohsawa T; Hirata W; Higichi S
Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
[TBL] [Abstract][Full Text] [Related]
13. Single bedtime dose of famotidine: assessment of its antisecretory action by 24-hour intragastric pH monitoring.
Savarino V; Picciotto A; Magnolia MR; Scalabrini P; Mela GS; Celle G
J Clin Pharmacol; 1987 Oct; 27(10):790-3. PubMed ID: 2892864
[TBL] [Abstract][Full Text] [Related]
14. Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man.
Grimley CE; West JM; Loft DE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
Aliment Pharmacol Ther; 1996 Oct; 10(5):743-7. PubMed ID: 8899082
[TBL] [Abstract][Full Text] [Related]
15. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.
Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Mappes A; Krammisch H; Heim J; Kaufmann D; Roehmel J
Gut; 1988 Jan; 29(1):81-4. PubMed ID: 2893761
[TBL] [Abstract][Full Text] [Related]
16. Low dose famotidine and cimetidine in single postprandial doses: a placebo controlled comparative study of overnight pH.
Reilly TG; Mann SG; Panos MZ; Walt RP
Gut; 1995 Sep; 37(3):325-8. PubMed ID: 7590425
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of the speed of acid-suppressing effects of oral administration of cimetidine and famotidine.
Adachi K; Komazawa Y; Mihara T; Azumi T; Fujisawa T; Katsube T; Furuta K; Kinoshita Y
J Gastroenterol Hepatol; 2005 Jul; 20(7):1012-5. PubMed ID: 15955208
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity.
Netzer P; Brabetz-Höfliger A; Bründler R; Flogerzi B; Hüsler J; Halter F
Aliment Pharmacol Ther; 1998 Apr; 12(4):337-42. PubMed ID: 9690722
[TBL] [Abstract][Full Text] [Related]
19. Famotidine in the therapy of gastric hypersecretory states.
Vinayek R; Howard JM; Maton PN; Wank SA; Slaff JI; Gardner JD; Jensen RT
Am J Med; 1986 Oct; 81(4B):49-59. PubMed ID: 2877575
[TBL] [Abstract][Full Text] [Related]
20. Four-day continuous gastric pH monitoring following anti-acid secretory drug administration: cross-over test to assess the early effects.
Suzuki T; Yamaguchi T; Odaka T; Kobayashi M; Seza A; Kouzu T; Yokosuka O
Aliment Pharmacol Ther; 2008 Jan; 27(1):66-71. PubMed ID: 17922801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
